Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out

Ann Oncol. 2018 Oct 1;29(10):2030-2032. doi: 10.1093/annonc/mdy342.

¹ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Ringgold Standard Institution, Milano, Italy. Electronic address: giuseppe.procopio@istitutotumori.mi.it.
² Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Ringgold Standard Institution, Milano, Italy.
³ Department of Urology and Gynecology, NCI, Naples, Italy.
⁴ Department of Clinical Therapeutics, National & Kapodistrian University of Athens, Athens, Greece.

No abstract available

Publication types